BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Jan. 22, 2003
View Archived Issues
Future Drugs Could Disrupt Protein Biosynthesis In Cancer
Read More
Procognia Closes $4M Round, Acquires Sense Proteomic Ltd.
Read More
Cyclacel Starts Phase II Trials Of Small-Molecule CDK Inhibitor
Read More
EU Leaders Support Worldwide Ban On Reproductive Cloning
Read More
ReNeuron Shares Drop On Failed Phase II Trials Of Lead Product
Read More
Second Complication Arises In French Gene Therapy Trial
Read More
Xenova Paying $1M For Rights To Two Addiction Vaccines
Read More
Adebag Planning Biotechnology Cluster In Southeastern France
Read More
Cerep Collaborates With Pfizer On BioPrint Database, Software
Read More
Other News To Note
Read More
Biolipox Raises EUR21M To Fund Drug Discovery, Development
Swedish drug discovery and development firm Biolipox AB raised €21 million in a second-round financing led by the Paris office of Apax Partners. (BioWorld International)
Read More
U.S. Officials Step Up Threats Over European Ban On GM Crops
Read More